Group 6 Copy 52
-2
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How oceanographic conditions affect the growth, diet, and survival of juvenile rockfish

    Rockfish are important fishery species on the U.S. West coast. Many rockfish species were overfished in the...

    Monitoring Bird Migration on Monomoy Island

    With the cooperation of US Fish and Wildlife and Monomoy National Wildlife Refuge, Monomoy Bird Observatory...

    Backer Badge Funded

    A biology project funded by 47 people